Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

MERS-CoV- Low risk to Canadians.

Identifieur interne : 001E32 ( Ncbi/Merge ); précédent : 001E31; suivant : 001E33

MERS-CoV- Low risk to Canadians.

Auteurs : M. Saboui ; F. Reyes-Domingo ; E. Levreault ; T. Mersereau

Source :

RBID : pubmed:29769862

Abstract

Middle East respiratory syndrome - Coronavirus (MERS-CoV) -- is a novel coronavirus that has caused a number of community-acquired cases and health care associated outbreaks in Saudi Arabia and the United Arab Emirates (UAE) as well as sporadic cases in other countries, especially in the Middle East. The evidence to date links MERS-CoV cases with exposure to camels, including camel products or to probable or confirmed human cases of MERS-CoV. It typically presents as an acute respiratory illness and is associated with a 35% mortality rate. Based on available information at this time, the current risk to Canadians for acquiring MERS-CoV infections is considered low. However, the International Health Regulations Committee concerning MERS-CoV has cautioned that the upsurge of cases seen this past spring (2014) may be predictive of an increase in cases related to the Hajj - an annual pilgrimage to Mecca in Saudi Arabia that took place in early October 2014. Although the overall risk is low, the Public Health Agency of Canada and its National Microbiology Laboratory (NML) in close collaboration with provincial and territorial partners, the Canadian Public Health Laboratory Network (CPHLN) and infection prevention and control experts have developed a number of preparedness guidance documents and protocols to address the risk of an imported case of MERS-CoV in Canada.

DOI: 10.14745/ccdr.v40i17a01
PubMed: 29769862

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:29769862

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">MERS-CoV- Low risk to Canadians.</title>
<author>
<name sortKey="Saboui, M" sort="Saboui, M" uniqKey="Saboui M" first="M" last="Saboui">M. Saboui</name>
<affiliation>
<nlm:affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</nlm:affiliation>
<wicri:noCountry code="subField">ON</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Reyes Domingo, F" sort="Reyes Domingo, F" uniqKey="Reyes Domingo F" first="F" last="Reyes-Domingo">F. Reyes-Domingo</name>
<affiliation>
<nlm:affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</nlm:affiliation>
<wicri:noCountry code="subField">ON</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Levreault, E" sort="Levreault, E" uniqKey="Levreault E" first="E" last="Levreault">E. Levreault</name>
<affiliation>
<nlm:affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</nlm:affiliation>
<wicri:noCountry code="subField">ON</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Mersereau, T" sort="Mersereau, T" uniqKey="Mersereau T" first="T" last="Mersereau">T. Mersereau</name>
<affiliation>
<nlm:affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</nlm:affiliation>
<wicri:noCountry code="subField">ON</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:29769862</idno>
<idno type="pmid">29769862</idno>
<idno type="doi">10.14745/ccdr.v40i17a01</idno>
<idno type="wicri:Area/PubMed/Corpus">001816</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001816</idno>
<idno type="wicri:Area/PubMed/Curation">001816</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001816</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001839</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001839</idno>
<idno type="wicri:Area/Ncbi/Merge">001E32</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">MERS-CoV- Low risk to Canadians.</title>
<author>
<name sortKey="Saboui, M" sort="Saboui, M" uniqKey="Saboui M" first="M" last="Saboui">M. Saboui</name>
<affiliation>
<nlm:affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</nlm:affiliation>
<wicri:noCountry code="subField">ON</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Reyes Domingo, F" sort="Reyes Domingo, F" uniqKey="Reyes Domingo F" first="F" last="Reyes-Domingo">F. Reyes-Domingo</name>
<affiliation>
<nlm:affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</nlm:affiliation>
<wicri:noCountry code="subField">ON</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Levreault, E" sort="Levreault, E" uniqKey="Levreault E" first="E" last="Levreault">E. Levreault</name>
<affiliation>
<nlm:affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</nlm:affiliation>
<wicri:noCountry code="subField">ON</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Mersereau, T" sort="Mersereau, T" uniqKey="Mersereau T" first="T" last="Mersereau">T. Mersereau</name>
<affiliation>
<nlm:affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</nlm:affiliation>
<wicri:noCountry code="subField">ON</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Canada communicable disease report = Releve des maladies transmissibles au Canada</title>
<idno type="ISSN">1188-4169</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Middle East respiratory syndrome - Coronavirus (MERS-CoV) -- is a novel coronavirus that has caused a number of community-acquired cases and health care associated outbreaks in Saudi Arabia and the United Arab Emirates (UAE) as well as sporadic cases in other countries, especially in the Middle East. The evidence to date links MERS-CoV cases with exposure to camels, including camel products or to probable or confirmed human cases of MERS-CoV. It typically presents as an acute respiratory illness and is associated with a 35% mortality rate. Based on available information at this time, the current risk to Canadians for acquiring MERS-CoV infections is considered low. However, the International Health Regulations Committee concerning MERS-CoV has cautioned that the upsurge of cases seen this past spring (2014) may be predictive of an increase in cases related to the Hajj - an annual pilgrimage to Mecca in Saudi Arabia that took place in early October 2014. Although the overall risk is low, the Public Health Agency of Canada and its National Microbiology Laboratory (NML) in close collaboration with provincial and territorial partners, the Canadian Public Health Laboratory Network (CPHLN) and infection prevention and control experts have developed a number of preparedness guidance documents and protocols to address the risk of an imported case of MERS-CoV in Canada.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">29769862</PMID>
<DateRevised>
<Year>2019</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Print">1188-4169</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>40</Volume>
<Issue>17</Issue>
<PubDate>
<Year>2014</Year>
<Month>Oct</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>Canada communicable disease report = Releve des maladies transmissibles au Canada</Title>
<ISOAbbreviation>Can. Commun. Dis. Rep.</ISOAbbreviation>
</Journal>
<ArticleTitle>MERS-CoV- Low risk to Canadians.</ArticleTitle>
<Pagination>
<MedlinePgn>339-345</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Middle East respiratory syndrome - Coronavirus (MERS-CoV) -- is a novel coronavirus that has caused a number of community-acquired cases and health care associated outbreaks in Saudi Arabia and the United Arab Emirates (UAE) as well as sporadic cases in other countries, especially in the Middle East. The evidence to date links MERS-CoV cases with exposure to camels, including camel products or to probable or confirmed human cases of MERS-CoV. It typically presents as an acute respiratory illness and is associated with a 35% mortality rate. Based on available information at this time, the current risk to Canadians for acquiring MERS-CoV infections is considered low. However, the International Health Regulations Committee concerning MERS-CoV has cautioned that the upsurge of cases seen this past spring (2014) may be predictive of an increase in cases related to the Hajj - an annual pilgrimage to Mecca in Saudi Arabia that took place in early October 2014. Although the overall risk is low, the Public Health Agency of Canada and its National Microbiology Laboratory (NML) in close collaboration with provincial and territorial partners, the Canadian Public Health Laboratory Network (CPHLN) and infection prevention and control experts have developed a number of preparedness guidance documents and protocols to address the risk of an imported case of MERS-CoV in Canada.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Saboui</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Reyes-Domingo</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Levreault</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mersereau</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Centre for Immunization and Respiratory Infectious Diseases (CIRID), Public Health Agency of Canada, Ottawa, ON.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Canada</Country>
<MedlineTA>Can Commun Dis Rep</MedlineTA>
<NlmUniqueID>9303729</NlmUniqueID>
<ISSNLinking>1188-4169</ISSNLinking>
</MedlineJournalInfo>
<CoiStatement>Conflict of interest: There are no conflicts of interest to declare.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>5</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>10</Month>
<Day>16</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29769862</ArticleId>
<ArticleId IdType="pmc">PMC5864465</ArticleId>
<ArticleId IdType="doi">10.14745/ccdr.v40i17a01</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2013 Aug 24;382(9893):694-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23831141</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2014 Jan;14 (1):50-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24239323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2014 Oct 1;210(7):1067-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24620019</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Levreault, E" sort="Levreault, E" uniqKey="Levreault E" first="E" last="Levreault">E. Levreault</name>
<name sortKey="Mersereau, T" sort="Mersereau, T" uniqKey="Mersereau T" first="T" last="Mersereau">T. Mersereau</name>
<name sortKey="Reyes Domingo, F" sort="Reyes Domingo, F" uniqKey="Reyes Domingo F" first="F" last="Reyes-Domingo">F. Reyes-Domingo</name>
<name sortKey="Saboui, M" sort="Saboui, M" uniqKey="Saboui M" first="M" last="Saboui">M. Saboui</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E32 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001E32 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:29769862
   |texte=   MERS-CoV- Low risk to Canadians.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:29769862" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021